This company should receive information soon about whether or not the FDA will approve CoStasis. I'm hoping for a $22.00 target for the end of the year. This is a good buy under $10.50.Best,CT
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimate